Many developing countries cannot free up public money to invest in economic stimulus packages. For them to join in the global recovery, they will need assistance.
Teens have acutely felt the effects of the pandemic lockdowns on their social lives. As the end of stay-at-home orders draws nearer, it’s important to consider teenagers’ social and emotional needs.
The pandemic’s not over yet, but these world leaders have already cemented their place in history for failing to effectively combat the deadly coronavirus. Some of them didn’t even really try.
Disasters highlight the cost of society’s love of efficiency. Nature, in contrast, favors resilience. Being more like nature offers benefits for society, especially in the face of the climate crisis.
It’s feasible to bring home at least some of the COVID-positive Australians stranded in India. Here’s how we can do it while keeping infection risk at a minimum.
While the results are very promising, it has only been tested in mice. Human clinical trials will take some time to complete before we know whether a drug could become available.
Insights of neuroscientist Ian McGilchrist, philosopher Nel Noddings and physicist Ursula Franklin help centre students and our collective future in debates about education and technology.
The United States and Canada have approved the Pfizer vaccine for adolescents aged 12–15. The evidence so far tells us it works well and is safe for this age group.
The mental health crisis occurring in tandem with COVID-19 has stressed resources and stretched service waitlists into years. There is an urgent need for prevention strategies, not just treatment.
Isabelle Brocas, USC Dornsife College of Letters, Arts and Sciences
Governments and companies are using incentives in hopes of getting more Americans to get a COVID-19 shot. A behavioral economist explains how they work.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand